{"id":"https://openalex.org/W597862084","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","title":"Effect of early discontinuation and nonadherence to adjuvant hormone therapy on mortality in women with breast cancer.","display_name":"Effect of early discontinuation and nonadherence to adjuvant hormone therapy on mortality in women with breast cancer.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W597862084","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","mag":"597862084"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.578","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112700316","display_name":"DL Hershman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. L. Hershman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T. H. Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. H. Shao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031698839","display_name":"Lawrence H. Kushi","orcid":"https://orcid.org/0000-0001-9136-1175","observed_orcids":["https://orcid.org/0000-0001-9136-1175"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Kushi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022428492","display_name":"Donna L. Buono","orcid":"https://orcid.org/0000-0002-3888-0758","observed_orcids":["https://orcid.org/0000-0002-3888-0758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Buono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049426719","display_name":"WY Tsai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Tsai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089385120","display_name":"Lou Fehrenbacher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Fehrenbacher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082554584","display_name":"Alfred I. Neugut","orcid":"https://orcid.org/0000-0002-5949-4522","observed_orcids":["https://orcid.org/0000-0002-5949-4522"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. I. Neugut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"578","last_page":"578"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.836899995803833,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.836899995803833,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.1388999968767166,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/early-discontinuation","display_name":"early discontinuation","score":0.7080000042915344},{"id":"https://openalex.org/keywords/medication-non-adherence","display_name":"medication non-adherence","score":0.8130000233650208},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.8949999809265137},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7630000114440918},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.6690000295639038},{"id":"https://openalex.org/keywords/kaiser-permanente","display_name":"Kaiser Permanente","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9511338472366333},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8609817028045654},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6872125864028931},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.6762945055961609},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.6709104776382446},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6201521754264832},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.551841676235199},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.5274239778518677},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46777310967445374},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44902077317237854},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.35718774795532227},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.578","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.578","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2071003201","https://openalex.org/W2134839096","https://openalex.org/W4380869680","https://openalex.org/W2006884661","https://openalex.org/W4303685167","https://openalex.org/W4412893617","https://openalex.org/W1973107513","https://openalex.org/W2946974818","https://openalex.org/W6907972583","https://openalex.org/W2083235931"],"abstract_inverted_index":{"578":[0],"Background:":[1],"Adjuvant":[2],"hormonal":[3,24,55,169,295,312],"therapy":[4,25,56,68,152,170,200,296,313],"reduces":[5],"mortality":[6,27,125],"among":[7,255],"women":[8,29,40,187,197,224,267],"with":[9,42,123,301],"hormone-sensitive":[10,43],"breast":[11],"cancer":[12],"(BC).":[13],"We":[14,38,62,109],"investigated":[15],"the":[16,74,88,94,97,101,117,172,176],"effects":[17],"of":[18,34,60,90,96,103,164,183,263,308],"early":[19,241,290],"discontinuation":[20,120,242,291],"and":[21,48,58,121,129,221,227,237,248,292,299,309],"nonadherence":[22,249],"to":[23,53,100,115,266,294,305,311,317,325],"on":[26],"in":[28,31,196,203,223],"enrolled":[30],"Kaiser":[32],"Permanente":[33],"Northern":[35],"California.":[36],"Methods:":[37],"identified":[39],"diagnosed":[41],"stage":[44],"I-III":[45],"BC,":[46],"1996-2006,":[47],"used":[49,110],"automated":[50],"pharmacy":[51],"records":[52],"identify":[54],"prescriptions":[57,270],"dates":[59],"refill.":[61],"categorized":[63,83],"patients":[64,84],"as":[65,85],"having":[66],"discontinued":[67,151,206],"if":[69,87],"180":[70],"days":[71,279],"elapsed":[72],"from":[73,93],"prior":[75],"prescription.":[76],"Of":[77,154,211],"those":[78,155,204,212,256,274],"who":[79,140,156,198,205,213,225,257,268,275],"continued":[80,157,199],"therapy,":[81,148,158],"we":[82],"adherent":[86],"number":[89],"pills":[91],"dispensed":[92],"date":[95,102],"first":[98],"prescription":[99,145],"treatment":[104],"completion":[105],"covered":[106],"\u2265":[107],"80%.":[108],"Cox":[111],"proportional":[112],"hazards":[113],"models":[114],"estimate":[116],"association":[118],"between":[119],"non-adherence":[122,293],"all-cause":[124],"controlling":[126],"for":[127,146,171,235],"socio-demographic":[128],"clinical":[130,236],"variables.":[131],"Results:":[132],"Among":[133],"8,769":[134],"women,":[135],"median":[136,181],"age":[137],"62":[138],"(24-99),":[139],"filled":[141],"at":[142,175,191,216],"least":[143],"one":[144],"hormone":[147],"2,790":[149],"(32%)":[150],"early.":[153],"1,666":[159],"(28%)":[160],"were":[161,259,297],"nonadherent":[162],"(19%":[163],"total).":[165],"Only":[166],"49%":[167],"took":[168],"full":[173],"duration":[174],"optimal":[177],"schedule.":[178],"During":[179],"a":[180],"follow-up":[182],"4.4":[184],"years,":[185],"813":[186],"died.":[188],"Estimated":[189],"survival":[190,215,282],"10":[192,217],"yrs":[193,218],"was":[194,219],"81%":[195],"versus":[201],"74%":[202],"(logrank,":[207,230],"p":[208,231],"<":[209,232],"0.001).":[210,233],"continued,":[214,258],"82%":[220],"78%":[222],"adhered":[226],"nonadhered,":[228],"respectively":[229],"Adjusting":[234],"demographic":[238],"variables,":[239],"both":[240],"(HR":[243,250,283],"1.36,":[244],"95%":[245,252,285],"CI":[246,253,286],"1.17-1.57)":[247],"1.40,":[251],"1.16-1.71),":[254],"significant":[260,322],"independent":[261],"predictors":[262],"mortality.":[264,303],"Compared":[265],"refilled":[269,276],"every":[271,277],"30":[272],"days,":[273],"90":[278],"had":[280],"improved":[281],"0.59,":[284],"0.51-0.71).":[287],"Conclusions:":[288],"Both":[289],"common":[298],"associated":[300],"increased":[302],"Interventions":[304],"improve":[306,318],"continuation":[307],"adherence":[310],"may":[314],"be":[315],"critical":[316],"BC":[319],"survival.":[320],"No":[321],"financial":[323],"relationships":[324],"disclose.":[326]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}